ÂÜÀòÂÒÂ×

John Vincent is a senior scientist with extensive expertise in drug discovery and assay development, particularly in oncology. Currently employed at Medicines Discovery Catapult since September 2020, John focuses on the development and screening of combination-based assays. Prior to this, John spent 23 years at AstraZeneca, serving in various senior research roles, including Senior Research Bioscientist in High Throughput Screening and Oncology. John possesses a strong background in developing assays and determining compound modes of action, utilizing a wide array of biochemical techniques. Academic credentials include a Bachelor of Science in Biochemistry and Genetics from the University of Nottingham.